Updates are available Correction dated 2022-11-03
Click to view Correction: https://doi.org/10.1038/s41591-022-02091-9
-
Authors
Mackensen, Andreas https://orcid.org/0000-0002-0685-4483
Müller, Fabian
Mougiakakos, Dimitrios
Böltz, Sebastian https://orcid.org/0000-0001-5227-8707
Wilhelm, Artur https://orcid.org/0000-0002-4637-1582
Aigner, Michael
Völkl, Simon
Simon, David https://orcid.org/0000-0001-8310-7820
Kleyer, Arnd https://orcid.org/0000-0002-2026-7728
Munoz, Luis
Kretschmann, Sascha
Kharboutli, Soraya
Gary, Regina
Reimann, Hannah https://orcid.org/0000-0002-7336-2008
Rösler, Wolf
Uderhardt, Stefan
Bang, Holger
Herrmann, Martin https://orcid.org/0000-0002-0258-2484
Ekici, Arif Bülent https://orcid.org/0000-0001-6099-7066
Buettner, Christian
Habenicht, Katharina Marie
Winkler, Thomas H. https://orcid.org/0000-0002-1860-0528
Krönke, Gerhard https://orcid.org/0000-0002-7566-4325
Schett, Georg https://orcid.org/0000-0001-8740-9615
- License Information
-
More Information
Article History
Received: 4 July 2022
Accepted: 18 August 2022
First Online: 15 September 2022
Competing interests
: There are no competing interests related to this study. The study received no commercial funding. F.M., S.B., A.W., M.A., S.V., D.S., A.K., L.M., S. Kretschmann, S. Kharboutli, R.G., H.R., W.R., S.U., M.H., A.B.E., C.B., K.M.H. and T.W. declare no competing interests. A.M. received speaker honoraria from BMS, Celgene, Gilead, Janssen, KITE, Miltenyi Biomedicine and Novartis, which were not related to this study. G.K. has received speaker honoraria from AbbVie, BMS, Eli Lilly, GSK, Janssen, Novartis and Sanofi. D.M. received speaker honoraria from AbbVie, Amgen, AstraZeneca, BMS, Celgene, Gilead, Hexal, Jazz Pharmaceuticals, Miltenyi Biomedicine, Novartis, Roche and Takeda, which were not related to this study. H.B. is employee of Orgentec and provided quantitative analyses for autoantibodies against nuclear antigens free of charge. G.S. received speaker honoraria from AbbVie, Janssen and Novartis, which were not related to this study.
